Delving into the details, we found 51% of traders were bullish, while 25% showed bearish tendencies. Out of all the trades we ...

As of market close on Friday, Jan. 24, Moderna stock is up 21.6% this week. Here's why.

Moderna wins EU tender to supply COVID-19 vaccines for up to four years, offering diverse formats like prefilled syringes to ...

Agreement,: Moderna will supply its mRNA COVID-19 vaccine to 17 participating countries in the EU, Norway, and North ...

The Agreement provides participating countries with the opportunity to diversify their mRNA COVID-19 vaccine supply and gain access to pre-filled syringe vaccine formats CAMBRIDGE, MA / ACCESS Newswir ...

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

Moderna, Inc. (NASDAQ:MRNA) institutional owners may be pleased with recent gains after 65% loss over the past year Given the large stake in the stock by institutions, Moderna's stock price might be ...

"We remain focused on our three strategic priorities: driving sales growth, delivering up to 10 product approvals over the ...

The article " After a Reset Year, Is Moderna Stock Poised for a Comeback? " first appeared on MarketBeat.

An adult human body consists of some 37 trillion cells. Not so long ago, these were thought to come in 220 different types.

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.